Mechanism and Dynamics of Bronchial Hyper-reactivity to Methacholine in Distal Airway on Obese Patients With Asthma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

35 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-06-30

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

New insights of small airway contribution to asthma have been gained. Poor levels of control and recurrent exacerbations were shown to have the phenotypic counterpart of asthma with predominant small airway involvement. Very few pathological specificities were identified at this site: mast cells infiltration was suggested as the specific inflammatory change when compared to the proximal airways.Biomarkers in asthma are still complex to validate, especially in the blood, since compartmentalisation is intense in the lung and the airways, a property attributed to the filtering role of the lung to maintain homeostasis. Over the last few years, Fraction exhaled Nitric Oxide (FENO) was developed as a non-invasive and indirect reflection of airway eosinophilic inflammation\]. In the blood, peripheral eosinophil counts were shown as a correct T helper 2 (TH2)-phenotype identifier but not perfectly related to airway eosinophilic infiltration. Club cell secretory protein (SCGB1A1) levels have been shown to have some relevance in asthma, chronic obstructive pulmonary disease (COPD), BOS, sarcoidosis, and lung cancer.A biomarker for small airway disease in asthma may improve the management of the disease, identify areas of therapeutic resistance and constitute a therapeutic guidance tool. In this study, investigators aimed to assess small airway involvement in asthmatic women as far as they could. For this purpose, investigators analysed trends in air trapping by acquiring expiratory CT slices at each dose during a bronchoprovocation test with metacholine. Biomarkers were subsequently tested and confronted to clinical and demographical characteristics in their ability to predict the small airway involvement index obtained at CT.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of Bronchial Thickness Using MRI in Asthma

NCT03089346

Asthma

UNKNOWN NA

Causes, Characteristics and Mechanisms of Infective Exacerbations in Subjects With Asthma and Chronic Obstructive Pulmonary Disease (COPD)

NCT00512954

Asthma COPD

COMPLETED

Qualitative Assessment of Patients Suffering From Difficult Asthma

NCT05185375

Asthma

UNKNOWN

Evaluation of Novel Lung Function Parameters in Patients With Bronchial Asthma

NCT03820427

Bronchial Asthma Pulmonary Healthy Controls

COMPLETED

EFFECT OF SMOKING ON MUCUS HYPERSECRETION MECHANISMS IN ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE

NCT01947218

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients will be recruited in the respiratory department of University Hospital in Montpellier (France) from June 2012 to March 2014. All patients are asthmatics, in order to avoid any gender-related biases, investigators decided to include only women. All participants had normal range spirometry, specifically regarding forced expiratory volume. Each patient will undergo a bronchial provocation test coupled with a thoracic CT scan. Bronchial and alveolar Nitric Oxyde will also be measured, a blood sample will be obtained in order to measure biomarker concentrations, and the patients will be asked to answer the validated Asthma Control Questionnaire in order to quantify asthma control.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal weight

Included patients with a BMI \< 25 will be part of this group.

metacholine provocation test and CT-scan low dose

Intervention Type OTHER

Investigators perform a metacholine provocation test where expiratory CT slices were acquired at each dose

Overweight

Included patients with a BMI \>= 25 and \<30 will be part of this group.

metacholine provocation test and CT-scan low dose

Intervention Type OTHER

Investigators perform a metacholine provocation test where expiratory CT slices were acquired at each dose

Obese

Included patients with a BMI \>= 30 will be part of this group.

metacholine provocation test and CT-scan low dose

Intervention Type OTHER

Investigators perform a metacholine provocation test where expiratory CT slices were acquired at each dose

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

metacholine provocation test and CT-scan low dose

Investigators perform a metacholine provocation test where expiratory CT slices were acquired at each dose

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female \>= 18 yrs
* Asthma
* Treated with Inhaled Corticosteroid (ICS)
* normal range spirometry

Exclusion Criteria

* Patients with other respiratory disease
* Patients with myocardial infarction (for 3 month before enrollment)
* Patients with cerebrovascular accident (for 3 month before enrollment)
* Patients with arterial aneurysm known
* Patients in pregnancy
* Patients nursing

Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No